DHA-PC and DHA-PS improved Aβ1-40 induced cognitive deficiency uncoupled with an increase in brain DHA in rats

Journal of Functional Foods

Volumn 22, Issue , 2016, Pages 417-430

  Wen, Min ^a   Ding, Lin ^a   Zhang, Lingyu ^a   Zhou, Miaomiao ^a   Xu, Jie ^a   Wang, Jingfeng ^a   Wang, Yuming ^a   Xue, Changhu ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Alzheimer's disease; Apoptosis; A 1 40; DHA PLs; Hyper phosphorylated tau; Inflammation

Indexed keywords

EID: 84961970540     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.02.004     Document Type: Article

References (94)

1. Akbar M., Calderon F., Wen Z., Kim H.Y. Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(31):10858-10863.
2. Anderson A.J., Su J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. Journal of Neuroscience 1996, 16(5):1710-1719.
3. Arsenault D., Julien C., Tremblay C., Calon F. DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS ONE 2011, 6(2):e17397.
4. Astarita G., Jung K.M., Berchtold N.C., Nguyen V.Q., Gillen D.L., Head E., Cotman C.W., Piomelli D. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS ONE 2010, 5(9):e12538.
5. Bader Lange M.L., Cenini G., Piroddi M., Abdul H.M., Sultana R., Galli F., Memo M., Butterfield D.A. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease. Neurobiology of Disease 2008, 29(3):456-464.
6. Barcelo-Coblijn G., Hogyes E., Kitajka K., Puskas L.G., Zvara A., Hackler L., Nyakas C., Penke Z., Farkas T. Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(20):11321-11326.
7. Bazan N.G. Neuroprotectin D1 (NPD1): A DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathology (Zurich, Switzerland) 2005, 15(2):159-166.
8. Bliss T.V., Collingridge G.L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993, 361(6407):31-39.
9. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nature Reviews Neuroscience 2007, 8(1):57-69.
10. Cai Z., Zhao Y., Zhao B. Roles of glycogen synthase kinase 3 in Alzheimer's disease. Current Alzheimer Research 2012, 9(7):864-879.
11. Calderini G., Teolato S., Bonetti A.C., Battistella A., Toffano G. Effect of lyso-phosphatidylserine on rat hypothalamic cAMP, in vivo. Life Sciences 1981, 28(21):2367-2375.
12. Casamenti F., Mantovani P., Amaducci L., Pepeu G. Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat. Journal of Neurochemistry 1979, 32(2):529-533.
13. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. Journal of Immunology 1992, 149(8):2736-2741.
14. Chen S. Highly pure phospholipids based brain docosahexaenoic acid transporters. Recent Patents CNS Drug Discovery 2010, 5(2):135-146.
15. Chung S.Y., Moriyama T., Uezu E., Uezu K., Hirata R., Yohena N., Masuda Y., Kokubu T., Yamamoto S. Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. The Journal of Nutrition 1995, 125(6):1484-1489.
16. Corwin J., Dean R.L., Bartus R.T., Rotrosen J., Watkins D.L. Behavioral effects of phosphatidylserine in the aged Fischer 344 rat: Amelioration of passive avoidance deficits without changes in psychomotor task performance. Neurobiology of Aging 1985, 6(1):11-15.
17. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged. Archives of Neurology 2009, 66(3):300-305. 10.1001/archneurol.2009.27.
18. Delwaide P.J., Gyselynck-Mambourg A.M., Hurlet A., Ylieff M. Double-blind randomized controlled study of phosphatidylserine in senile demented patients. Acta Neurologica Scandinavica 1986, 73(2):136-140.
19. Ding N., Xue Y., Tang X., Sun Z.M., Yanagita T., Xue C.H., Wang Y.M. Short-term effects of different fish oil formulations on tissue absorption of docosahexaenoic acid in mice fed high- and low-fat diets. Journal of Oleo Science 2013, 62(11):883-891.
20. Drago F., Canonico P.L., Scapagnini U. Behavioral effects of phosphatidylserine in aged rats. Neurobiology of Aging 1981, 2(3):209-213.
21. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 1996, 382(6593):716-719.
22. Elyaman W., Terro F., Wong N.S., Hugon J. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: Links to tau phosphorylation. The European Journal of Neuroscience 2002, 15(4):651-660.
23. Florent S., Malaplate-Armand C., Youssef I., Kriem B., Koziel V., Escanye M.C., Fifre A., Sponne I., Leininger-Muller B., Olivier J.L., Pillot T., Oster T. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. Journal of Neurochemistry 2006, 96(2):385-395.
24. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957, 226(1):497-509.
25. Fraser T., Tayler H., Love S. Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochemical Research 2010, 35(3):503-513.
26. Freyz L., Dreyfus J., Vincendon C. Asymmetry of brain microsomal membrances. Phospholipids in the nervous system 1982, 37-47. Raven Press, New York. L. Horrocks (Ed.).
27. Gillette-Guyonnet S., Secher M., Vellas B. Nutrition and neurodegeneration: Epidemiological evidence and challenges for future research. British Journal of Clinical Pharmacology 2013, 75(3):738-755.
28. Glomset J.A. Role of docosahexaenoic acid in neuronal plasma membranes. Science's STKE 2006, 2006(321):pe6.
29. Green K.N., Martinez-Coria H., Khashwji H., Hall E.B., Yurko-Mauro K.A., Ellis L., LaFerla F.M. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. Journal of Neuroscience 2007, 27(16):4385-4395.
30. Griffin W.S. Inflammation and neurodegenerative diseases. The American Journal of Clinical Nutrition 2006, 83(2):470S-474S.
31. Guo M., Stockert L., Akbar M., Kim H.Y. Neuronal specific increase of phosphatidylserine by docosahexaenoic acid. Journal of Molecular Neuroscience 2007, 33(1):67-73.
32. Hamilton L., Greiner R., Salem N., Kim H.Y. n-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues. Lipids 2000, 35(8):863-869.
33. Hanger D.P., Anderton B.H., Noble W. Tau phosphorylation: The therapeutic challenge for neurodegenerative disease. Trends in Molecular Medicine 2009, 15(3):112-119.
34. Hashiguchi M., Hashiguchi T. Kinase-kinase interaction and modulation of tau phosphorylation. International Review of Cell Molecular Biology 2013, 300:121-160.
35. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., Ishibashi Y., Oka J., Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. Journal of Neurochemistry 2002, 81(5):1084-1091.
36. Hiratsuka S., Ishihara K., Kitagawa T., Wada S., Yokogoshi H. Effect of dietary docosahexaenoic acid connecting phospholipids on the lipid peroxidation of the brain in mice. Journal of Nutritional Science and Vitaminology 2008, 54(6):501-506.
37. Hjorth E., Zhu M., Toro V.C., Vedin I., Palmblad J., Cederholm T., Freund-Levi Y., Faxen-Irving G., Wahlund L.O., Basun H., Eriksdotter M., Schultzberg M. Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-beta42 by human microglia and decrease inflammatory markers. Journal of Alzheimer's Disease 2013, 35(4):697-713.
38. Hosokawa M., Shimatani T., Kanada T., Inoue Y., Takahashi K. Conversion to docosahexaenoic acid-containing phosphatidylserine from squid skin lecithin by phospholipase D-mediated transphosphatidylation. Journal of Agricultural and Food Chemistry 2000, 48(10):4550-4554.
39. Huang B.X., Akbar M., Kevala K., Kim H.Y. Phosphatidylserine is a critical modulator for Akt activation. The Journal of Cell Biology 2011, 192(6):979-992.
40. Huang H.C., Xu K., Jiang Z.F. Curcumin-mediated neuroprotection against amyloid-beta-induced mitochondrial dysfunction involves the inhibition of GSK-3beta. Journal of Alzheimer's Disease 2012, 32(4):981-996.
41. Jin M., Shepardson N., Yang T., Chen G., Walsh D., Selkoe D.J. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(14):5819-5824.
42. Junjaud G., Rouaud E., Turpin F., Mothet J.P., Billard J.M. Age-related effects of the neuromodulator d-serine on neurotransmission and synaptic potentiation in the CA1 hippocampal area of the rat. Journal of Neurochemistry 2006, 98(4):1159-1166.
43. Kalaria R.N. Microglia and Alzheimer's disease. Current Opinion in Hematology 1999, 6(1):15-24.
44. Kawakita E., Hashimoto M., Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 2006, 139(3):991-997.
45. Keramaris E., Stefanis L., MacLaurin J., Harada N., Takaku K., Ishikawa T., Taketo M.M., Robertson G.S., Nicholson D.W., Slack R.S., Park D.S. Involvement of caspase 3 in apoptotic death of cortical neurons evoked by DNA damage. Molecular and Cellular Neurosciences 2000, 15(4):368-379.
46. Kim H.G., Ju M.S., Park H., Seo Y., Jang Y.P., Hong J., Oh M.S. Evaluation of Samjunghwan, a traditional medicine, for neuroprotection against damage by amyloid-beta in rat cortical neurons. Journal of Ethnopharmacology 2010, 130(3):625-630.
47. Kim H.G., Oh M.S. Herbal medicines for the prevention and treatment of Alzheimer's disease. Current Pharmaceutical Design 2012, 18(1):57-75.
48. Kim H.Y. Novel metabolism of docosahexaenoic acid in neural cells. The Journal of Biological Chemistry 2007, 282(26):18661-18665.
49. Kim H.Y., Akbar M., Lau A., Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. The Journal of Biological Chemistry 2000, 275(45):35215-35223.
50. Kim H.Y., Bigelow J., Kevala J.H. Substrate preference in phosphatidylserine biosynthesis for docosahexaenoic acid containing species. Biochemistry 2004, 43(4):1030-1036.
51. Kim H.Y., Huang B.X., Spector A.A. Phosphatidylserine in the brain: Metabolism and function. Progress in Lipid Research 2014, 56:1-18.
52. Lee B., Sur B.J., Han J.J., Shim I., Her S., Lee H.J., Hahm D.H. Krill phosphatidylserine improves learning and memory in Morris water maze in aged rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010, 34(6):1085-1093.
53. Lee Y.K., Kwak D.H., Oh K.W., Nam S.Y., Lee B.J., Yun Y.W., Kim Y.B., Han S.B., Hong J.T. CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function. Neurobiology of Learning and Memory 2009, 92(3):356-363.
54. Lim S.Y., Suzuki H. Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice. The Journal of Nutrition 2000, 130(6):1629-1632.
55. Lim G.P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., Salem N., Frautschy S.A., Cole G.M. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. Journal of Neuroscience 2005, 25(12):3032-3040.
56. Liu T., Bai W., Wang J., Tian X. An aberrant link between gamma oscillation and functional connectivity in Abeta-mediated memory deficits in rats. Behavioural Brain Research 2015, 297:51-58.
57. Liu G., Wang T., Wang T., Song J., Zhou Z. Effects of apoptosis-related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia rats. Biomedical Reports 2013, 1(6):861-867.
58. Liu X., Xue Y., Liu C., Lou Q., Wang J., Yanagita T., Xue C., Wang Y. Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids in Health and Disease 2013, 12:109.
59. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25(4):402-408.
60. Lu J., Wu D.M., Zheng Y.L., Hu B., Zhang Z.F. Purple sweet potato color alleviates D-galactose-induced brain aging in old mice by promoting survival of neurons via PI3K pathway and inhibiting cytochrome C-mediated apoptosis. Brain Pathology (Zurich, Switzerland) 2010, 20(3):598-612.
61. Ma Q.L., Yang F., Rosario E.R., Ubeda O.J., Beech W., Gant D.J., Chen P.P., Hudspeth B., Chen C., Zhao Y., Vinters H.V., Frautschy S.A., Cole G.M. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin. Journal of Neuroscience 2009, 29(28):9078-9089.
62. Mantovani P., Pepeu G., Amaducci L. Investigations into the relationship between phospholipids and brain acetylcholine. Advances in Experimental Medicine and Biology 1976, 72:285.
63. Markesbery W.R. The role of oxidative stress in Alzheimer disease. Archives of Neurology 1999, 56(12):1449-1452.
64. Mazanetz M.P., Fischer P.M. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nature Reviews Drug Discovery 2007, 6(6):464-479.
65. Meda L., Cassatella M.A., Szendrei G.I., Otvos L., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374(6523):647-650.
66. Mei J.M., Niu C.S. Effects of CDNF on 6-OHDA-induced apoptosis in PC12 cells via modulation of Bcl-2/Bax and caspase-3 activation. Neurological Sciences 2014, 35(8):1275-1280.
67. Miller M.G., Shukitt-Hale B. Berry fruit enhances beneficial signaling in the brain. Journal of Agricultural and Food Chemistry 2012, 60(23):5709-5715.
68. Mines M.A., Beurel E., Jope R.S. Regulation of cell survival mechanisms in Alzheimer's disease by glycogen synthase kinase-3. International Journal of Alzheimer's Disease 2011, 2011:861072.
69. Mothet J.P., Rouaud E., Sinet P.M., Potier B., Jouvenceau A., Dutar P., Billard J.M. A critical role for the glial-derived neuromodulator d-serine in the age-related deficits of cellular mechanisms of learning and memory. Aging Cell 2006, 5(3):267-274.
70. Murthy M., Hamilton J., Greiner R.S., Moriguchi T., Salem N., Kim H.Y. Differential effects of n-3 fatty acid deficiency on phospholipid molecular species composition in the rat hippocampus. Journal of Lipid Research 2002, 43(4):611-617.
71. Nelson V.M., Dancik C.M., Pan W., Jiang Z.G., Lebowitz M.S., Ghanbari H.A. PAN-811 inhibits oxidative stress-induced cell death of human Alzheimer's disease-derived and age-matched olfactory neuroepithelial cells via suppression of intracellular reactive oxygen species. Journal of Alzheimer's Disease 2009, 17(3):611-619.
72. Nitsch R.M., Blusztajn J.K., Pittas A.G., Slack B.E., Growdon J.H., Wurtman R.J. Evidence for a membrane defect in Alzheimer disease brain. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(5):1671-1675.
73. Papanicolaou K.N., Ngoh G.A., Dabkowski E.R., O'Connell K.A., Ribeiro R.F., Stanley W.C., Walsh K. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. American Journal of Physiology, Heart and Circulatory Physiology 2012, 302(1):H167-H179.
74. Paxinos G., Watson s. The rat brain in stereotaxic coordinates 1986, Academic, New York.
75. Pepeu G., Pepeu I.M., Amaducci L. A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain?. Pharmacological Research 1996, 33(2):73-80.
76. Pettegrew J.W., Panchalingam K., Hamilton R.L., McClure R.J. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochemical Research 2001, 26(7):771-782.
77. Petursdottir A.L., Farr S.A., Morley J.E., Banks W.A., Skuladottir G.V. Lipid peroxidation in brain during aging in the senescence-accelerated mouse (SAM). Neurobiology of Aging 2007, 28(8):1170-1178.
78. Pi R., Mao X., Chao X., Cheng Z., Liu M., Duan X., Mingzhong Y., Xiaohong C., Zhengrong M., Peiqing L., Wenming L., Han Y. Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-beta-mediated Alzheimer's disease-associated pathogenesis in vitro and in vivo. PLoS ONE 2012, 7(2):e31921.
79. Qu M.H., Yang X., Wang Y., Tang Q., Han H., Wang J., Wang G.D., Xue C., Gao Z. Docosahexaenoic acid-phosphatidylcholine improves cognitive deficits in an Aβ23-35-induced Alzheimer's disease rat model. Current Topics in Medicinal Chemistry 2016, 16(5):558-564.
80. Querfurth H.W., Laferla F.M. Alzheimer's disease. New England Journal of Medicine 2010, 362(19):1844-1845.
81. Sadli N., Barrow C.J., McGee S., Suphioglu C. Effect of DHA and coenzymeQ10 against Abeta- and zinc-induced mitochondrial dysfunction in human neuronal cells. Cell Physiol Biochem and Pharmacology 2013, 32(2):243-252.
82. Salem N., Litman B., Kim H.Y., Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001, 36(9):945-959.
83. Shipton O.A., Leitz J.R., Dworzak J., Acton C.E., Tunbridge E.M., Denk F., Dawson H.N., Vitek M.P., Wade-Martins R., Paulsen O., Vargas-Caballero M. Tau protein is required for amyloid -induced impairment of hippocampal long-term potentiation. Journal of Neuroscience 2011, 31(5):1688-1692.
84. Shleper M., Kartvelishvily E., Wolosker H. D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices. Journal of Neuroscience 2005, 25(41):9413-9417.
85. Solfrizzi V., Panza F., Frisardi V., Seripa D., Logroscino G., Imbimbo B.P., Pilotto A. Diet and Alzheimer's disease risk factors or prevention: The current evidence. Expert Review of Neurotherapeutics 2011, 11(5):677-708.
86. Stevens E.R., Esguerra M., Kim P.M., Newman E.A., Snyder S.H., Zahs K.R., Miller R.F. D-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors. Proceedings of the National Academy of Sciences 2003, 100(11):6789-6794.
87. Su H.M. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. The Journal of Nutritional Biochemistry 2010, 21(5):364-373.
88. Tang X., Li Z.J., Xu J., Xue Y., Li J.Z., Wang J.F., Yanagita T., Xue C.H., Wang Y.M. Short term effects of different omega-3 fatty acid formulation on lipid metabolism in mice fed high or low fat diet. Lipids in Health and Disease 2012, 11:70. 10.1186/1476-511X-11-70.
89. Teng E., Taylor K., Bilousova T., Weiland D., Pham T., Zuo X., Yang F., Chen P.P., Glabe C.G., Takacs A., Hoffman D.R., Frautschy S.A., Cole G.M. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization. Neurobiology of Disease 2015, 82:552-560. 10.1016/j.nbd.2015.09.002.
90. Thummayot S., Tocharus C., Pinkaew D., Viwatpinyo K., Sringarm K., Tocharus J. Neuroprotective effect of purple rice extract and its constituent against amyloid beta-induced neuronal cell death in SK-N-SH cells. Neurotoxicology 2014, 45:149-158.
91. Waldmeier P.C., Tatton W.G. Interrupting apoptosis in neurodegenerative disease: Potential for effective therapy?. Drug Discovery Today 2004, 9(5):210-218.
92. Xu J., Zhang R., Zuo P., Yang N., Ji C., Liu W., Wang Y., Wang H., Wu A., Yue Y., Liu Y. Aggravation effect of isoflurane on Aβ(25-35)-induced apoptosis and tau hyperphosphorylation in PC12 cells. Cellular and Molecular Neurobiology 2012, 32(8):1343-1351.
93. Yuki D., Sugiura Y., Zaima N., Akatsu H., Takei S., Yao I., Maesako M., Kinoshita A., Yamamoto T., Kon R., Sugiyama K., Setou M. DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease. Scientific Reports 2014, 4:7130.
94. Zussy C., Brureau A., Delair B., Marchal S., Keller E., Ixart G., Naert G., Meunier J., Chevallier N., Maurice T., Givalois L. Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid beta fragment in rats. The American Journal of Pathology 2011, 179(1):315-334.